http://rdf.ncbi.nlm.nih.gov/pubchem/reference/4589831

Outgoing Links

Predicate Object
contentType Journal Article
issn 1663-9812
pageRange 199-
publicationName Frontiers in Pharmacology
startingPage 199
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_8ab1483ea7c29eb5f255243f7d5ac132
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0c24f0a1d4f3da07bfa7d30f51c2ba7e
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d16de7ec64b7ae6d48cf494e889e0a25
bibliographicCitation Nishimura Y, Sasagawa S, Ariyoshi M, Ichikawa S, Shimada Y, Kawaguchi K, Kawase R, Yamamoto R, Uehara T, Yanai T, Takata R, Tanaka T. Systems pharmacology of adiposity reveals inhibition of EP300 as a common therapeutic mechanism of caloric restriction and resveratrol for obesity. Front. Pharmacol. 2015 Sep 15;6(). doi: 10.3389/fphar.2015.00199.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4756bc1ac93bf160907169522d6fd296
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_82e97128405650ec56aeb64dc8dafd7e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6751267be00ce792b63f2979749957a2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab4778c17d48fccac32cd77685fca1a0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d3b647d7825594a14ebabf205b2b45c0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b83cf2c9372978c6323381aa2993a1a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b7372e535ba5485af0f031cb7c631e0b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4a909570fe916663f950ac95e39dcc77
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2841d040088504d464c222dba6e40d83
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5c518e5d3e0a58e6406d9d8c5b49183e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4b05d0f1b47e16ad2b40d7bca2c55f69
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_188678ac6629b72b45579af8a403551f
date 2015-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.3389/fphar.2015.00199
https://pubmed.ncbi.nlm.nih.gov/PMC4569862
https://pubmed.ncbi.nlm.nih.gov/26441656
isPartOf https://portal.issn.org/resource/ISSN/1663-9812
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/38627
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Systems pharmacology of adiposity reveals inhibition of EP300 as a common therapeutic mechanism of caloric restriction and resveratrol for obesity
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8679
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e724967faf79eca1e0f57bf0c14a4576
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a867f4e256fa541dbe7391509d8bdab1
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445154
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cbd49b6b6dca61836d467343918a59ff
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e0075ed0b539cd222faf4e9c05f0d358
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a335344aada7b95b103c25396798c66e
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444493
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_85be224aa48f1786b1036470a769ce24

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID327320
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID140615
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID252819665
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID352926
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID402948
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID30255
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID376229668
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID317638
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID321195
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID321421
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53787604

Total number of triples: 51.